| |
|
|
|
Citius Pharmaceuticals Inc  
|
|
0.9715 0.012 (0.01%) |
06-05 11:24 |
|
Open: |
0.99 |
Pre close: |
0.96 |
Target:
|
1.31
|
|
High: |
0.99 |
Low: |
0.95 |
Resistance:
|
1.12
1.31
|
|
Volume: |
761,663 |
Market Cap: |
44M |
Support:
|
0.90
0.77
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.94
 |
MACD |
MACD(12,26):
|
0.03 |
|
MA(20): |
0.91 |
Signal(12,26,9): |
0.03 |
|
MA(100): |
0.84 |
Stochastic Oscillator |
%K(14,3):
|
68.57 |
|
MA(250): |
0.84  |
%D(3): |
56.59 |
|
Average Volume(K) |
3-Month: |
144799
|
52-Week |
High:
|
1.50 |
|
10-Days: |
259137 |
Low: |
0.40 |
|
RSI |
RSI(14):
|
59.13 |
Change(%): |
-7.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.623 |
Return on Equity (ttm) |
-77.6 |
Shares Out. (M) |
45.19 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-41.8 |
Shares Float (M) |
22.02 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
39.08 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
12.53 |
|
Forward EPS |
-1.170 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1190 |
|
Book Value (p.s.) |
0.590 |
EBITDA (p.s.) |
-0.375 |
P/E |
-1.57 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.66 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-16.01 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-9.72 |
P/CF |
-2.77 |
|
|
|
|
|
|
